P-Cure ^{For Profit}

P-Cure is a company that offers a compact FDA-cleared solution for treating cancer patients using proton therapy. Their system can fit into existing or new radiation therapy centers and is designed from the patient and physician perspective. The company aims to reduce the magnitude of internal organ motion and improve imaging resolution. P-Cure's treatment solution is expected to yield improved dose distribution, thereby exposing healthy tissues and organs to significantly less radiation. Their gantry-less system can significantly reduce the cost of the initial investment required to establish proton therapy services. P-Cure's solution is comparable in size to single floor linac rooms, requires 50 percent less shielding, and can reduce the capital costs of a proton center by 50 percent. The company operates globally with production, service, and R&D platforms in the US, Israel, and China. Contact info: N/A.